Godavari Biorefineries Limited — Important, 15-07-2025: Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

Godavari Biorefineries has secured a significant patent grant from China's National Intellectual Property Administration (CNIPA) for its compound, "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER." This patent covers novel compounds that have demonstrated strong inhibitory effects on cancer and cancer stem cells in lab studies. The compounds showed efficacy against various cancer types, including breast and prostate cancer. This intellectual property win in a major market like China strengthens the company's position in cancer research, signaling potential for future drug development and long-term value creation in the therapeutic space.